Genezen Announces the Appointment of Key Executive Leaders, Expanding Viral Vector Capabilities

Genezen, a gene and cell therapy contract development and manufacturing organization, announced the appointment of Susan D’Costa, Ph.D. as Chief Technology Officer and Nicole O’Brien, Ph.D. as Chief Commercial Officer.